Cargando…
Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Japan
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910493/ https://www.ncbi.nlm.nih.gov/pubmed/29134328 http://dx.doi.org/10.1007/s00535-017-1409-z |
| _version_ | 1783316058790166528 |
|---|---|
| author | Kumada, Hiromitsu Watanabe, Tsunamasa Suzuki, Fumitaka Ikeda, Kenji Sato, Ken Toyoda, Hidenori Atsukawa, Masanori Ido, Akio Takaki, Akinobu Enomoto, Nobuyuki Kato, Koji Alves, Katia Burroughs, Margaret Redman, Rebecca Pugatch, David Pilot-Matias, Tami J. Krishnan, Preethi Oberoi, Rajneet K. Xie, Wangang Chayama, Kazuaki |
| author_facet | Kumada, Hiromitsu Watanabe, Tsunamasa Suzuki, Fumitaka Ikeda, Kenji Sato, Ken Toyoda, Hidenori Atsukawa, Masanori Ido, Akio Takaki, Akinobu Enomoto, Nobuyuki Kato, Koji Alves, Katia Burroughs, Margaret Redman, Rebecca Pugatch, David Pilot-Matias, Tami J. Krishnan, Preethi Oberoi, Rajneet K. Xie, Wangang Chayama, Kazuaki |
| author_sort | Kumada, Hiromitsu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5910493 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Japan |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59104932018-04-24 Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection Kumada, Hiromitsu Watanabe, Tsunamasa Suzuki, Fumitaka Ikeda, Kenji Sato, Ken Toyoda, Hidenori Atsukawa, Masanori Ido, Akio Takaki, Akinobu Enomoto, Nobuyuki Kato, Koji Alves, Katia Burroughs, Margaret Redman, Rebecca Pugatch, David Pilot-Matias, Tami J. Krishnan, Preethi Oberoi, Rajneet K. Xie, Wangang Chayama, Kazuaki J Gastroenterol Correction Springer Japan 2017-11-13 2018 /pmc/articles/PMC5910493/ /pubmed/29134328 http://dx.doi.org/10.1007/s00535-017-1409-z Text en © The Author(s) 2017 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction Kumada, Hiromitsu Watanabe, Tsunamasa Suzuki, Fumitaka Ikeda, Kenji Sato, Ken Toyoda, Hidenori Atsukawa, Masanori Ido, Akio Takaki, Akinobu Enomoto, Nobuyuki Kato, Koji Alves, Katia Burroughs, Margaret Redman, Rebecca Pugatch, David Pilot-Matias, Tami J. Krishnan, Preethi Oberoi, Rajneet K. Xie, Wangang Chayama, Kazuaki Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection |
| title | Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection |
| title_full | Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection |
| title_fullStr | Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection |
| title_full_unstemmed | Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection |
| title_short | Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection |
| title_sort | correction to: efficacy and safety of glecaprevir/pibrentasvir in hcv-infected japanese patients with prior daa experience, severe renal impairment, or genotype 3 infection |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910493/ https://www.ncbi.nlm.nih.gov/pubmed/29134328 http://dx.doi.org/10.1007/s00535-017-1409-z |
| work_keys_str_mv | AT kumadahiromitsu correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT watanabetsunamasa correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT suzukifumitaka correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT ikedakenji correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT satoken correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT toyodahidenori correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT atsukawamasanori correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT idoakio correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT takakiakinobu correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT enomotonobuyuki correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT katokoji correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT alveskatia correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT burroughsmargaret correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT redmanrebecca correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT pugatchdavid correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT pilotmatiastamij correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT krishnanpreethi correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT oberoirajneetk correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT xiewangang correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection AT chayamakazuaki correctiontoefficacyandsafetyofglecaprevirpibrentasvirinhcvinfectedjapanesepatientswithpriordaaexperiencesevererenalimpairmentorgenotype3infection |